Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Cancer Biotherapy & Radiopharmaceuticals|October 21, 2000
Tumor-absorbed-dose estimates versus response in tositumomab therapy of previously untreated patients with follicular non-Hodgkin's lymphoma: preliminary reportK F Koral, Y Dewaraja, L A Clarke, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 20, 2000
Initial results for Hybrid SPECT--conjugate-view tumor dosimetry in 131I-anti-B1 antibody therapy of previously untreated patients with lymphomaK F Koral, Y Dewaraja, J Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
I-131 anti-B1 therapy/tracer uptake ratio using a new procedure for fusion of tracer images to computed tomography imagesK F Koral, J Li, Y Dewaraja, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomasJ M Vose, R L Wahl, M Saleh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphomaM S Kaminski, L M Fig, K R Zasadny, et al.The New England Journal of Medicine|August 12, 1993
Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibodyM S Kaminski, K R Zasadny, I R Francis, et al.Blood|August 15, 2000
Radioimmunotherapy with iodine (131)I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experienceM S Kaminski, J Estes, K R Zasadny, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphomaM S Kaminski, K R Zasadny, I R Francis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2001
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomasM S Kaminski, A D Zelenetz, O W Press, et al.Blood Cancer Journal|June 1, 2014
The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomasR Briski, A L Feldman, N G Bailey, et al.Pageof 5